Pharmaceutical Companies Invest $350 Billion in the US: Industry Chain Competition and Strategic Restructuring Under the Pressure of Tariffs
Under the shadow of the Trump administration's tariff threats, global pharmaceutical giants are embarking on an unprecedented "wave of investment in the US."
more